These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3313065)

  • 21. Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin.
    Chuang JI; Chang TY; Liu HS
    Oncogene; 2003 Mar; 22(9):1349-57. PubMed ID: 12618760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The v-mos and c-Ha-ras oncoproteins exert similar effects on the pattern of protein synthesis.
    Klemenz R; Hoffmann S; Jaggi R; Werenskiold AK
    Oncogene; 1989 Jun; 4(6):799-803. PubMed ID: 2525241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth factors, oncogenes and inositol lipids.
    Berridge MJ
    Cancer Surv; 1986; 5(2):413-30. PubMed ID: 3779662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of bcl-2 in growth factor triggered signal transduction.
    Haldar S; Reed JC; Beatty C; Croce CM
    Cancer Res; 1990 Nov; 50(22):7399-401. PubMed ID: 2121338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signal transduction in EJ-H-ras-transformed cells: de novo synthesis of diacylglycerol and subversion of agonist-stimulated inositol lipid metabolism.
    Chiarugi VP; Magnelli L; Pasquali F; Basi G; Ruggiero M
    FEBS Lett; 1989 Jul; 252(1-2):129-34. PubMed ID: 2668028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
    Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
    J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phorbol ester-induced production of cytostatic factors by normal and oncogenic Ha-ras-transformed human breast cell lines.
    Guo M; Reiners JJ
    Carcinogenesis; 2000 Jul; 21(7):1303-12. PubMed ID: 10874007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid stimulation of diacylglycerol production in Xenopus oocytes by microinjection of H-ras p21.
    Lacal JC; de la Peña P; Moscat J; Garcia-Barreno P; Anderson PS; Aaronson SA
    Science; 1987 Oct; 238(4826):533-6. PubMed ID: 2821623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2.
    Wasylyk C; Bradford AP; Gutierrez-Hartmann A; Wasylyk B
    Oncogene; 1997 Feb; 14(8):899-913. PubMed ID: 9050989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
    Wang B; Soule HD; Miller FR
    Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells.
    Cheng G; Meinkoth JL
    Oncogene; 2001 Nov; 20(50):7334-41. PubMed ID: 11704863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrin signaling to NF-kappa B in monocytic leukemia cells is blocked by activated oncogenes.
    Rosales C; Juliano R
    Cancer Res; 1996 May; 56(10):2302-5. PubMed ID: 8625304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
    Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
    Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ernst Klenk Lecture, November 1985. Intracellular signalling through inositol trisphosphate and diacylglycerol.
    Berridge MJ
    Biol Chem Hoppe Seyler; 1986 Jun; 367(6):447-56. PubMed ID: 3017379
    [No Abstract]   [Full Text] [Related]  

  • 38. Ha-ras stimulates the transplasma membrane oxidoreductase activity of C3H10T1/2 cells.
    Crowe RA; Taparowsky EJ; Crane FL
    Biochem Biophys Res Commun; 1993 Oct; 196(2):844-50. PubMed ID: 8240360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of cytokinesis and akt phosphorylation by chaetoglobosin K in ras-transformed epithelial cells.
    Matesic DF; Villio KN; Folse SL; Garcia EL; Cutler SJ; Cutler HG
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):741-54. PubMed ID: 16254733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
    Kivinen L; Pitkänen K; Laiho M
    Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.